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The aryl hydrocarbon receptor (AHR) is a ligand-inducible tran-
scription factor that is best known because it mediates the actions
of polycyclic and halogenated aromatic hydrocarbon environmen-
tal toxicants such as 3-methylcholanthrene and 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin. We report here the successful identification of
an endogenous ligand for this receptor; 20 g was isolated in
pure form from 35 kg of porcine lung. Its structure was deduced as
2-(1H-indole-3-carbonyl)-thiazole-4-carboxylic acid methyl ester
from extensive physical measurements and quantum mechanical
calculations. In a reporter gene assay, this ligand activates the AHR
with a potency five times greater than that of -naphthoflavone,
a prototypical synthetic AHR ligand. 2-(1H-indole-3-carbonyl)-
thiazole-4-carboxylic acid methyl ester competes with 2,3,7,8-
[3H]tetrachlorodibenzo-p-dioxin for binding to human, murine,
and fish AHRs, thus showing that AHR activation is caused by direct
receptor binding, and that recognition of this endogenous ligand
is conserved from early vertebrates (fish) to humans.
The Ah locus was first defined in inbred mice as a straindifference in response to treatment with polycyclic aromatic
hydrocarbons such as 3-methylcholanthrene (1). The evidence
for the presence of a receptor encoded by the locus was then
provided by characterizing the strain-specific and stereo-specific
binding sites in mouse liver cytoplasm (2). The coding sequence
for the receptor, a soluble protein named aryl hydrocarbon
receptor (AHR), was eventually identified and characterized (3).
The receptor is found in many vertebrates including fish. The
AHR is a ligand-inducible transcription factor, a member of a
basic helix–loop–helixPer-Arnt-Sim (bHLHPAS) family. On
binding to xenobiotic ligands, the AHR has been shown to
regulate the expression of a variety of genes including those
encoding for cytochrome P450 enzymes. In addition, receptor
activation has been linked to alterations in cell proliferation,
apoptosis, adipose differentiation, tumor promotion, immune
function, vitamin A status, development, and reproductive func-
tions (4–9). The generation of AHR-deficient mice also points
to possible physiological functions of the receptor in liver, heart,
ovary, and vascular and immune systems (7, 10–12).
The AHR is best known because polycyclic aromatic hydro-
carbons, such as 3-methylcholanthrene and benzo[]pyrene, and
halogenated aromatic hydrocarbons, such as 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD), serve as ligands (1, 13). Although
the ability of AHR to bind a variety of xenobiotic ligands is of
great interest, it is clear that the AHR did not evolve to respond
to manufactured chemicals. It is reasonable to suspect that
endogenous ligands must exist for the AHR. Recently, two
human urinary products were isolated that bind to the AHR (14).
Whether those products are physiological AHR ligands or not is
undetermined because the identified compounds are indigo, a
commonly used fabric dye, and indirubin, an isomer of indigo.
For the past few years we have labored under the assumption that
endogenous ligands exist for the AHR in tissues of higher
vertebrates. We have now succeeded in isolating from porcine
lung tissue a ligand for AHR and have unequivocally identified
it as 2-(1H-indole-3-carbonyl)-thiazole-4-carboxylic acid
methyl ester (ITE) by UV and IR spectrophotometry, MS,
extensive NMR studies, and quantum mechanical calculations.
Materials and Methods
UV Spectroscopy. About 3 g of the ligand in 200 l of methanol
water (60:40, volvol) was injected into a cyano HPLC column
(Adsorbosphere CN-AQ 5U, i.d.  4.6 mm, Alltech Associates)
equilibrated with 60% methanol in water at a flow rate of 0.5
mlmin. Compounds eluted from the column passed through the
flow cell (path length, 10 mm; i.d., 0.009 inches) of a Waters 996
photodiode array detector. The UV absorbance of the mobile
phase was automatically set to zero. UV absorption spectra were
recorded with MILLENNIUM 3.2 software (Waters) at a rate of one
spectrum per s. The spectrum acquired at the moment of the
highest UV absorption is shown.
Electron Impact MS. A new glass probe was inserted into a
MS50TC Ultrahigh Resolution Mass Spectrometer (Kratos An-
alytical Instruments), with electron energy of 70 eV and ion
source temperature of 150°C. The instrument and probe were at
first operated in this mode until a satisfactory background was
achieved. A blank spectrum of the residue of column effluent
eluting at the retention time of the putative ligand was recorded.
The sample (200 ng) was then introduced on the same probe
and the spectrum was taken. Any signal common to both the
blank and the sample spectrum was subtracted generating the
spectrum reported. A KRATOS DS-55 data acquisition system was
used to record all spectroscopic data.
Fourier Transform (FT)-IR Spectroscopy. One microgram of the
ligand in methanol was spotted onto a Teflon STI IR Card
(Thermo Spectra-Tech, Shelton, CT). The sample was applied to
the card in such a way that the area through which the smallest
diameter IR beam passes was kept at a minimum to maximize the
sample path length with limited supply of material. The solvent
was evaporated and the card was placed in the sample chamber
of an Infinity 60 AR FT-IR Spectrometer (Thermo-Mattson,
Madison, WI). The spectrum was acquired with WINFIRST 3.00
software (resolution, 2; scan number, 200; Iris opening, 1%;
window, KBr). A blank spectrum was generated by using the
residue from the HPLC effluent as described for MS.
One-Dimensional NMR Spectroscopy. Two micrograms of the ligand
in specified solvents was placed in either a 2.5-mm NMR sample
tube (Wilmad–Labglass, Buena, NY) or a 5-mm Shigemi tube
(Shigemi, Allison Park, PA). The magnetic susceptibility of the
Shigemi tube was adjusted to that of the solvent. The standard
1H NMR, single-frequency decoupling, and single frequency
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nuclear Overhauser effect difference spectra were obtained on
Bruker DMX-750 and DMX-500 spectrometers (Bruker, Bil-
lerica, MA). The spectrum of a blank produced as described for
MS was also recorded.
Two-Dimensional NMR Spectroscopy. Twelve micrograms of the
ligand in deuterated methanol was placed in a 5-mm Shigemi
tube (Shigemi). The two-dimensional 1H{13C} heteronuclear
single quantum correlation (HSQC) and heteronuclear multiple-
bond correlation (HMBC) experiments were performed on the
DMX-500 equipped with a 5-mm triple-resonance, single-axis
gradient Cryoprobe (Bruker). In the case of the HMBC exper-
iment, the direct peaks were not suppressed and a refocusing
180° pulse was applied to both 1H and 13C resonances at the
midpoint of the antiphase buildup period to refocus static field
inhomogeneities.
Quantum Mechanical Calculations. Proposed structures were con-
structed by using the GAUSSVIEW program (Gaussian, Carnegie,
PA). These models were subjected to full, unconstrained geom-
etry optimization at the B3LYP6–31g* level of theory by using
the JAGUAR quantum chemical program (Schrodinger, Portland,
OR). The absence of imaginary frequencies assured that the
models were in a local ground state. Calculated frequencies were
scaled by using the Modified Scaled Quantum Mechanical Force
Fields (SQM) method on the optimized structures (15). Isotropic
chemical shifts were calculated from optimized models by using
the GAUSSIAN suite of quantum chemical programs. The Gauge
Including Atomic Orbital method at the B3LYP6 –
311g(2d,2p) level of theory as implemented in GAUSSIAN 98
was used for the calculations. Calculated chemical shifts were
calibrated versus experimental chemical shifts of some model
compounds and the theoretical values were scaled empirically
(16–18) by using the following linear equations: experimental
shift (1H, ppm)  calculated shift  0.95  0.26; experimental
shift (13C, ppm)  calculated shift  0.95  0.59. The R2 values
for the linear regressions were 0.999 for both 1H and 13C fits.
Expected deviations of the calibrated theoretical chemical shifts
from experimental values are 0.15 ppm (16) for 1H and 3
ppm for 13C (18). The theoretical proton and carbon shifts of
tetramethysilane were set to zero.
Coupling constants were calculated by the single-finite-
perturbation method (19). The magnitude of the perturbation
was 0.02 atomic units, which is within the linear region of
response, and the calculation was performed at the B3LYP6–
311g* level of theory. In this method, only the Fermi contact
contribution to the scalar coupling is available.
Identities of Protons and Carbons in Structure Analysis. For the
convenience of identification of atoms in the compound, protons
and carbons are named after their chemical shifts. For example,
a proton with a chemical shift of 9.25 ppm will be named as 9.25
proton and, similarly, a carbon of 141.05 ppm as 141 carbon.
Cell Culture and Reporter Gene Assay. The cell line H1L1.1C2 (20)
was maintained in a culture medium (DMEM 10% FBS) with
G418 at a concentration of 400 gml and incubated at 37°C in
6% CO2. A 96-well, sterile cell culture plate with about 30,000
cells per well in 200 l of culture medium without G418 was
prepared and incubated for at least 12 h before dosing with AHR
ligands in DMSO (0.5% in culture medium) for the reporter
gene assay. The cells were incubated for an additional 4 h after
dosing. The cells were washed twice with PBS (pH 6.9) and lysed
by adding 50 l of Cell Culture Lysis Reagent (Promega). Lysate
from each well (10 l) was transferred into a corresponding well
of a Microlite 2 plate (Dynex Technologies, Chantilly, VA). A
MLX Microtiter Plate Luminometer (Dynex Technologies) was
programmed to inject 50 l of a luciferase substrate solution
(Promega) into each well, and the light intensities in relative light
units generated were recorded (for 5 s after a 1-s delay) and
averaged.
Receptor Binding Studies. Aryl hydrocarbon receptors (human,
murine, killfish, and zebrafish) were expressed by in vitro tran-
scription and translation by using the TnT Quick-coupled Re-
ticulocyte Lysate Systems reaction (Promega). Receptor ligand
binding was studied by velocity sedimentation on sucrose gra-
dients (21). The transcription and translation reactions were
diluted 8-fold, divided into 100-l aliquots containing 14
Fig. 1. AHR ligand purification and UV spectrum. (a) Flow chart showing the steps taken in purifying the ligand. (b) The photodiode array representation of
an HPLC chromatogram of the purified AHR ligand (3g). x axis, retention time in minutes; y axis, wavelengths monitored in nanometers; z axis, UV absorbance.
(c) UV spectrum of the AHR ligand. The spectrum was taken at an HPLC retention time of10 min, at which moment the UV absorbance reached the maximum.
x axis, wavelengths in nm; y axis, UV absorbance.








reaction each, and incubated overnight at 4°C with [3H]TCDD
(2 nM) ITE at the concentrations shown. Incubation mixtures
were fractionated (150 l per fraction) on gradients of 10–30%
sucrose. For competition binding studies, transcription and
translation expressed murine AHR was incubated with
[3H]TCDD (2 nM) in the absence or presence of increasing
concentrations of unlabeled ITE, -naphthoflavone (BNF), or
TCDD. Bound ligand was separated from that free in solution
by adsorption to hydroxylapatite (22) and washing by using a
filter manifold (23).
Results
Extraction and Purification of the Ligand. In preliminary work with
rats, lung seemed to have the highest concentration of AHR
ligand activity. By using 35 kg of porcine lung tissue as a source
of ligand, we isolated 20 g of ligand (flow chart shown in Fig.
1a). Material (20 g) was estimated on the basis of the reporter
gene assay using BNF as the standard. This estimate assumes that
the isolated ligand has the same activity as BNF, which proved
to be a good approximation. After the final purification, an
HPLC analytical column revealed a single substance (Fig. 1b).
Chemical Identification of the Ligand. The UV absorption spectrum
of the ligand revealed a maximum at 356 and another double
maximum at 277 nm (Fig. 1c). The absorption spectrum suggests
a highly conjugated structure. High-resolution electron impact
MS revealed a molecular ion of 286.0399 giving an empirical
formula of C14H10N2O3S (Fig. 2a; Table 1). The presence of
sulfur is evidenced by the appearance of an isotope cluster that
shows the characteristic abundance of M  2 ion heavily
contributed by 34S. With only 10 protons, a highly condensed
multiringed compound was expected. The mass fragmentation
analysis also revealed a base fragment at 144.0453 or C9H6NO.
Clearly the sulfur-containing moiety was lost during the frag-
mentation to its most stable ion.
Our attention next shifted to NMR spectroscopy in an attempt
to characterize the nature of the protons and their connectivity
relationships to carbons in the molecule (Fig. 3). Three protons
Fig. 2. Electron impact mass and Fourier transform-IR spectra. (a) High-
resolution electron impact mass spectrum of the AHR ligand. x axis, the ratio
of mass to charge, mz; y axis, relative abundance of ions. The ligand structure
showing the formation of the major fragments is presented. Proposed frag-
mentation pathways are as mapped under the spectrum. (b) Fourier trans-
form-IR spectrum of the AHR ligand. x axis, the frequencies of IR beam
expressed as wavenumber (cm1). The region from 1,000 to 3,000 cm1 is
shown here. y axis, the absorbance. Signals with clear attribution are as
labeled.
Fig. 3. Proton NMR spectrum and proton-carbon-13 correlations. (a) 1H NMR
spectrum of the AHR ligand in d-methanol. The peak labeled Solvent is
contributed from NMR solvent. No signal existed in the solvent masked area
confirmed by examining a spectrum taken in d-chloroform (data not shown).
Signals contributed from numbers and locations of the protons are as labeled.
(b) Table of 1H-13C correlation of the AHR ligand from both HSQC and HMBC
spectra. The protons and carbon-13s with detectable connections are listed in
the same row. The carbon-13s listed under a column headed HSQC are the
ones directly connected (through one bond) to the corresponding proton(s)
(in the same row), whereas the ones under the columns headed HMBC are
connected to the corresponding proton(s) through 2–3 bonds.
Table 1. Principal high-resolution electron impact mass
fragments of the AHR ligand
Mass Abundance, % Composition Deviation
288.0414 4.22 C14H10N2O334S 14.93
287.0441 14.21 13C112C13H10N2O3S 2.79
286.0399 69.19 C14H10N2O3S 4.89
285.0361 4.64 C14H9N2O3S 9.23
145.0495 12.50 13C112C8H6NO 9.80
144.0453 100.00 C9H6NO 2.22
143.0383 2.89 C9H5NO 8.04
117.0550 5.13 13C112C7H6N 11.28
116.0503 28.98 C8H6N 1.90
115.0435 2.02 C8H5N 10.87
89.0393 12.00 C7H5 1.68
88.0401 1.80 C7H4 99.74
Other fragments will be reported in detail elsewhere.
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are found at 3.99 ppm as a singlet and are methyl protons. Of
particular importance is the presence of a carboxylic methyl ester
group. Besides the high-resolution MS and the fragmentation
analysis revealed in Fig. 2a and Table 1, the presence of a methyl
ester group was revealed by the elimination of biological activity
when the ligand was treated with 0.1 M KOH. The activity was
largely restored by methylation with diazomethane (data not
shown), strongly suggesting the presence of an ester group. The
presence of a methyl ester functionality is also revealed from the
IR spectrum with bands at 1,737 cm1 (ester CAO) and around
1,205 cm1 (ester COO) (Fig. 2b). Furthermore, both HSQC
and HMBC data support the presence of a methyl ester (Fig. 3b).
Four protons (7.27, 7.28, 7.50, and 8.36 protons) must be
attached to a six-membered aromatic ring judging from their
chemical shifts, results of decoupling and nuclear Overhauser
effect experiments (data not shown), and both HSQC and
HMBC data (Fig. 3b). This ring, in turn, is fused with a
five-membered aromatic ring on which the 9.25 proton is at-
tached (from HMBC data). The five-membered ring must be
heterocyclic, containing either a nitrogen or an oxygen because
the 144 base fragment in the mass spectrum is composed of
C9H6NO. However, the oxygen cannot be a component of the
five-membered ring because the chemical shifts of the two
carbons directly connected to the oxygen would have larger shifts
than observed in the HSQC and HMBC spectra. A nitrogen,
therefore, must be the component in the five-membered ring
resulting in an indole structure. The NMR signals of the proton
(11.33 ppm) attached to the indole nitrogen and the nuclear
Overhauser effect response of its neighboring (7.50 and 9.25)
protons to it were visible when d-acetone instead of d-methanol
was used as NMR solvent (data not shown). To satisfy the
composition of C9H6NO of the 144 base fragment in the mass
spectrum, one of the positions on the five-membered ring must
be substituted with either a CAO or COO moiety. Considering
the fact that both the 9.25 and 8.36 protons (Fig. 3) are highly
deshielded, a group must be located between the 9.25 and 8.36
protons. Thus, the 9.25 proton must be located between the
nitrogen and the substituted carbon, further confirming the
indole structure. The COO or CAO moiety could be a COO in
a six-membered ring, which would not deshield its neighboring
protons, or an attached ketone, which will highly deshield its
neighboring (9.25 and 8.36) protons. The presence of a ketone
on a carbon attached to the indole nucleus is revealed by the IR
spectrum providing a band at 1,593 cm1 (Fig. 2b), characteristic
of ketones on a carbon in the vicinity of an indole as revealed by
model compounds such as 3-benzoylindole [see Integrated Spec-
tral Data Base System (SDBS) for Organic Compounds, Na-
tional Institute of Advanced Industrial Science and Technology,
Tsukuba, Ibaraki, Japan; www.aist.go.jpriodbsdbs; ref. 24],
(cyclohex-1-en-1-yl)-3-indolylmethanone, and 3-(E-2-methyl-
but-2-enoyl)indole (24). Those same models also displayed a
unique feature of forming, by losing other fragments, the same
stable 144 (C9H6NO) mass fragment composed of indole and the
attached ketone. This ketone is attached to another five-
membered heteroaromatic ring (either thiazole or isothiazole).
Fig. 4. The structure and biochemical characterization of ITE. (a) The structure of the endogenous AHR ligand and its proton and carbon-13 chemical shifts
(same as their identification numbers). (b) Dose–response curves for ITE and BNF. The ability of ITE and BNF to activate a DRE-reporter gene construct is shown
(mean  SD). (c) Competition of ITE for specific [3H]TCDD binding to in vitro-synthesized murine (Upper) and human (Lower) AHRs as analyzed by velocity
sedimentation on sucrose density gradients. UPL refers to unprogrammed lysate (i.e., in vitro transcription and translation in the absence of AHR expression
plasmid), which serves as a measure of nonspecific binding in the velocity sedimentation analysis.








Considering the published (25) proton and carbon chemical
shifts of thiazole and isothiazole and the fact that the two other
positions will be substituted by two groups with deshielding
power, only the 5-position (numbering from S to N) can be
considered for the 8.67 proton attachment in the case of the
thiazole structure. With the 2- and 4-positions attached to the
ketone and the methyl ester, respectively, and vice versa, there
will be two possible structures based on thiazole. Similar to the
thiazole situation, there are two possible structures based on
isothiazole because only the 4-position can be considered for the
8.67-proton attachment.
The 1H-13C coupling constant for the 8.67 proton to its directly
attached carbon obtained from the HMBC spectrum is193 Hz.
We investigated the coupling constants between the position 5
proton and carbon in the thiazole and the position 4 proton and
the carbon in isothiazole. Faure et al. (26) and Tseng (27)
reported that the coupling constant between the position 5
proton and carbon in thiazole is 191 Hz and the range is from
188 to 200 with different substitutions at the other positions,
while the one between the position 4 proton and carbon in
isothiazole is 173 Hz and the range is from 168 to 171 with
different substitutions at the other positions. Furthermore, we
calculated the theoretical coupling constants for both thiazole-
and isothiazole-based structures. The theoretical coupling con-
stant between the 8.67 proton and its connected carbon in the
thiazole structure is 185.4 Hz, whereas that in the isothiazole-
based structure is 175.7 Hz. Judging from both theoretical
coupling constants and experimental values in the literature, the
isothiazole structures were eliminated. Of the thiazole struc-
tures, one is derived from cysteine in which the position 2 of
thiazole is substituted with a ketone and position 4 a methyl
ester. The other is a noncysteine-related structure with a re-
versed order of substitution.
Finally, the chemical shift theoretical calculations show that
the cysteine-related structure best fits the experimental values.
The standard deviation of the theoretical chemical shifts from
the experimental shifts was 2.07 ppm for the carbon nuclei and
0.098 ppm for the proton. This deduction is strongly supported
by experimental evidence reported in the literature. When an
aldehyde (equivalent to a ketone in this case) is connected to the
2-position of the thiazole, the chemical shift of carbon 2 is 166
ppm and carbon 4 is 146 ppm (28). When a methyl ester is
attached to the 4-position of the thiazole, the chemical shift of
carbon 4 is 146 ppm and the carbon 2 (with a methyl group
attached) is 167 ppm (29). We can, therefore, confidently deduce
that when an aldehyde or ketone is attached to carbon 2 and the
methyl ester to carbon 4 of a thiazole at the same time, similar
to the arrangement of the cysteine-related structure, the chem-
ical shifts of carbon 2 and 4 would be 166 and 146, respectively,
which agrees with both calculated and measured chemical shifts
for the structure. Similar analysis and calculations led to the
elimination of the noncysteine-related structure. Thus, the
cysteine-related structure was deduced as 2-(1H-indole-3-
carbonyl)-thiazole-4-carboxylic acid methyl ester, which we ab-
breviate as ITE (Fig. 4a). To be sure of the structure, chemical
synthesis was accomplished (to be reported elsewhere). As
shown in Fig. 5, the synthetic material exactly comigrates with
the isolated ligand on HPLC. Further, the biological response
curves using the reporter gene assay are identical for synthetic
and isolated ligand (Fig. 5).
Biochemical Characterization of the Ligand. Fig. 4b indicates that
ITE is about five times more potent than BNF in reporter gene
activity after 4 h of incubation. The agonist activity of ITE
through the AHR was demonstrated by the ability of an AHR
antagonist, 3-methoxy-4-nitroflavone (30), to block the re-
porter gene response to ITE in a dose-dependent fashion (data
not shown).
Competitive binding studies show that ITE inhibits binding of
[3H]TCDD to the AHR. Sucrose density gradient analyses
demonstrated that ITE not only competes effectively for binding
to the human and murine AHRs (Fig. 4c), but is equally effective
in competing for [3H]TCDD binding to AHRs from the killifish
Fundulus heteroclitus (AHR1 and AHR2) and the zebrafish
Danio rerio (data not shown). Competition for [3H]TCDD (2
nM) binding to the murine AHR by using a range of ITE, BNF,
and TCDD concentrations resulted in nearly equivalent binding
affinities for ITE and BNF, whereas TCDD showed slightly
higher binding affinity (Ki values for ITE, BNF, and TCDD of
3, 2, and 0.5 nM, respectively; data not shown). Thus, ITE is a
ligand that binds directly to the AHR to induce receptor activity.
Although ITE is similar to BNF in affinity for binding to the
AHR, it is more potent (5-fold) than BNF in transactivating
the DRE-containing reporter gene construct in Hepa1c1c7 cells.
The enhanced activity of ITE in transactivation could be caused
by greater stability or access to the nucleus, or alternatively, ITE
may induce a change in receptor conformation that is more
condusive to the binding of comodulatory proteins.
Discussion
Although it is likely that more than one endogenous ligand will
be found for the AHR, we have now demonstrated the existence
of one of these, which we obtained from lung tissue. The ability
of acid treatment of methanolic extracts to render the material
chloroform soluble suggests that the compound may exist as a
higher-order complex in tissue. Release of ITE from this com-
plex can also be accomplished in the absence of methanol ruling
out transesterification during the workup. A minor concern is
whether our acid treatment could generate ITE from inactive
components in the methanolic extract. We are unable to con-
ceive any reaction catalyzed by 2 N acid in aqueous methanol that
could yield ITE, but we cannot totally exclude it. Furthermore,
the fact that ITE is so active argues for its existence before
extraction.
Several groups have reported the identification of endogenous
ligands for the AHR. The closest example is the indigo-related
compounds isolated from human urine (14). However, because
Fig. 5. Comparison of isolated vs. synthetic ITE. An HPLC chromatograph
of a mixture of natural (20 ng) and synthetic (20 ng) ITE is shown. HPLC
condition: C18 analytical column (4.6  250 mm), methanolwater (70:30
volvol); flow rate  0.5 mlmin;   356 nm; x axis, retention time. y axis,
UV absorbance. (Insets) Dose–response curves (mean  SD) generated by
the natural (Left) and synthetic (Right) ITE, relative right units (ordinate) vs.
agonist concentration.
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these compounds were isolated from urine, the question of
whether they represent urinary excretion products from an
exogenous source or were generated from endogenous com-
pounds remains unanswered. Similarly, the lipoxin A(4) (31),
bilirubin-related compounds (32), and tryptophan-related com-
pounds (indole and tryptamine) (33) are certainly endogenous
but whether they are the true physiological ligands for AHR has
not yet been resolved.
The origin of ITE is very likely from tryptophan and cysteine
by an expected condensation reaction. Of course, this must be
investigated in vitro and in vivo. Even if the two fragments arise
from the two amino acids, exactly how it occurs will be of
considerable interest. Furthermore, whether the production of
this compound is regulated and in what way can now be
approached experimentally. The biological function of ITE is
difficult to ascertain at this moment. Based on the effects of
xenobiotics that bind AHR, a diverse group of functions for
ITE can be envisioned. With the availability of this ligand,
physiological functions of the AHR can now be directly
investigated.
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